International Journal of Gynecological Cancer

Article	Citations
Role of pre-diagnostic reproductive factors on long-term (10 years or greater) survival of epithelial ovarian cancer: The Extreme study	266
Computed tomography–based prediction of interval cytoreduction in advanced ovarian cancer	155
Patterns of care and development of quality indicators in patients with non-epithelial and rare ovarian tumors in Australia: insights from the National Gynae-Oncology Registry	124
Use of quadratus lumborum block in gynecologic procedures	116
Vulvar cancer resection with V–Y advancement flap reconstruction	98
Utilization of artificial intelligence to mitigate health inequalities in gynecological cancer care	91
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study	77
The Silva Pattern-Based Classification And Oncological Outcomes In Women Undergoing Fertility-Sparing Surgery For Early-Stage Cervical Cancer	66
Patient-initiated follow-up in low-risk endometrial cancer after surgery: a systematic review	63
Sarcopenia shortens overall survival of patients with platinum-resistant recurrent ovarian cancer: inverse probability of treatment-weighting analysis	60
To Compare The Colposcopic Findings By International Federation Of Colposcopy And Cervical Pathology (IFCPC ) Nomenclature And Swede Score For Assessment Of High Grade Cervical Lesions	59
Squamous Cell Carcinoma Arising In Mature Cystic Teratomas: A Case Series Review Of Presentation, Treatment, And Prognosis	53
The Role Of Prehabilitation In ERAS For Gynecologic Oncology In Germany	50
Prospective Multicentre Evaluation Of Secondary Cytoreductive Surgery In The Era Of PARP-Inhibitors (CONCEPT) In Relapsed Epithelial Ovarian Cancer	49
The Role Of Second-Look Surgery In Recurrent Ovarian Cancer Based On The Type Of Relapse	43
A Young Woman Presenting Virilization With Ovarian Mass: A Case Report Of Rare Disease - Ovarian Steroid Tumor	42
Trop-2 Expression In Cervical Carcinoma (CX) - A Possible Target For The Antibody Drug Conjugate Sacituzumab	41
Evaluating The Implementation And Outcomes Of The Tumor-First Testing Strategy For BRCA1/2 Pathogenic Variants In Ovarian Cancer Patients: A Center-Wide Analysis	41
Early-Stage Breast Cancer: A Detailed Examination Of Clinicopathological Features	41
The Prognostic And Predictive Value Of Cardiophrenic Lymph Nodes In Patients Receiving Hyperthermic Intraperitoneal Chemotherapy For Ovarian Cancer In The OVHIPEC-1 Trial	40
Excision Of Retroperitoneal Mass - Laparoscopic Management Of Iliac Artery Injury	40
Impact Of Ascites And Peritoneal Metastatic Lesion Volumes, Measured By Newly Developed Deep Learning-Based Algorithm, In Advanced Epithelial Ovarian Cancer	40
Does Sentinel Node Know The Cancer Origin? Comparing Sentinel Lymph Nodes Localization In Endometrial And Cervical Cancer	38
Advanced Techniques In Pelvic Exenteration For Cervical Cancer: A Case-Based Surgical Guide	38
PROGNOSTIC FACTORS BASED ON THE MOLECULAR CLASSIFICATION OF ENDOMETRIAL CANCER: SINGLE INSTITUTION STUDY	36

Surgical Release Of The Pudendal Nerve By Robotic Approach In 10 Steps	36
Does The Origin Of Ovarian Cancer Influence Outcomes?	36
Surgical Treatment Of Advanced Ovarian Cancer: Experience From A Brazilian Cancer Center (Barretos Cancer Hospital) In 2023	33
Secondary Debulking Followed By Localised Radiotherapy In Patients With Oligometastatic Recurrent Ovarian Cancer – A Case Series Of Two International Cancer Centres	33
The “N-PLUS/NOGGO-Ov53/ENGOT-Ov62-STUDY” To De-Escalate Chemotherapy In Ovarian Cancer: Comparing 3 Vs. 6 Cycles Of Platinum-Based Chemotherapy After Complete Tumor Resection Followed By Niraparib Mai	33
Controversies in the management of mucinous ovarian tumors	32
A Multivariable Prognostic Analysis For Survival Outcomes In Women With Epithelial Ovarian Cancer - A North Indian Single Centre Study	32
Prognostic Factors In Adult Granulosa Cell Tumours Of The Ovary And Long Term Follow-Up. (The Norwegian Radium Hospital Experience 1971-2024)	32
Comparative Outcomes Of Excision And Active Surveillance For Cervical Intraepithelial Neoplasia 2 In Women Under 35	31
Hepatic hilum cytoreductive surgery for ovarian cancer relapse☆	31
Survival Prediction And Mortality Risk Stratification In Ovarian Cancer After NACT: PRGS Outperforms CRS Regression Scoring	30
SPLEEN PRESERVING EXTENSIVE CYTOREDUCTIVE SURGERY	29
Impact Of Surgery On Survival Outcomes In Locally Advanced Cervical Cancer Patients With Partial Response After Primary Chemoradiotherapy	29
Impact Of Preoperative Conization On The Prognosis Of Cervical Cancer Patients Undergoing Open Abdominal Radical Hysterectomy	29
Histological Findings After Completion Hysterectomy And Clinical Outcome Following Conservative Treatment Of Endometrial Carcinoma	28
Homologous Recombination Deficiency (HRD) In P53 Abnormal Endometrial Carcinoma	27
Assessment Of The Predictive Role Of Khorana Score And Genomic Profiling In Ovarian Cancer-Related Venous Thromboembolism	26
Clinical Significance Of Low Volume Lymph Node Metastasis In Early Stage Cervical Cancer: A Single Centre Case Series	26
Perioperative Outcomes Of Heated Intraperitoneal Chemotherapy For Patients Enrolled In The Feasibility Phase Of A Randomized Controlled Trial: Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy	26
PARSGO and UM6SS: spearheading excellence in gynecological oncology in Morocco	25
Pocket guide based on the TNM and FIGO staging systems for classifying patients with locally advanced cervical cancer: a practical tool from the GINECO group for quick and easy management	24
Erratum to ‘Controversies in vulvar cancer: revisiting the margin of error’ [International Journal of Gynecological Cancer Volume 35 Issue 3 (2025) 101678]	24
Use of social media for academic and professional purposes by gynecologic oncologists	24
Correspondence on “Immune checkpoint inhibitor combinations for patients with advanced endometrial cancer: a network meta-analysis and cost-utility analysis” by Zhu and colleagues	24
Performance of molecular classification in predicting oncologic outcomes of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer	23
A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC)	23
Primary ovarian leiomyosarcoma: results from an analysis by the French Sarcoma Group (Ovarian SArcoma MAnagement – OSAMA Study)	22
ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancer	22
A population-based study of outcomes in adjuvant radiotherapy for stage II endometrial carcinoma	21
Inguinofemoral lymphadenectomy technique in 10 steps	21
Three-dimensional image of uterine transposition	21
The Cukurova score in the prediction of primary cytoreduction in ovarian cancer	21
Growing teratoma syndrome	21
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeins	21
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization	21
Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy	21
Laparoscopic approach to paravaginal low-grade sarcoma	20
Correspondence on ‘Enhanced recovery after surgery in gynecologic oncology: time to address barriers to implementation in low- and middle-income countries’ by Nelson et al	20
Surgical technique and surgeon volume: the pursuit of data-driven outcomes	20
Successful cervical cancer treatment during a monochorionic diamniotic twin pregnancy in a patient with history of preterm delivery	20
Surgical staging for locally-advanced cervical cancer: the answer remains ‘NO’	20
ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation	20
Evaluating the use of machine learning in endometrial cancer: a systematic review	19
Correction: SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer	19
Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico	19
Well-differentiated papillary mesothelial tumor of the peritoneum	19
Complementary use of indocyanine green and technetium to enhance sentinel lymphadenectomy in vulvar cancer	19
Management of stage III and IVa uterine cancer	19
Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer	18
Vaginal cuff brachytherapy for endometrial cancer: a review of major clinical trials with a focus on fractionation	18

Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer	18
Safety and management of niraparib monotherapy in ovarian cancer clinical trials	17
Dual mechanical and pharmacological thromboprophylaxis decreases risk of pulmonary embolus after laparotomy for gynecologic malignancies	17
Epithelial ovarian cancer and borderline tumors during pregnancy: a report from the International Network on Cancer, Infertility, and Pregnancy	17
A fully next-generation sequencing-based method of classifying molecular sub-types of endometrial cancer retains prognostic value and expands biomarker targets	17
Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcoma	17
Improvement in radiation techniques for locally advanced cervical cancer during the last two decades	17
Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research a	17
Best original research presented at the 25th European Congress on Gynaecological Oncology: best of ESGO 2024	17
22nd meeting of the European Society of Gynaecological Oncology (ESGO 2021) report	16
Fertility-sparing treatment in early-stage cervical adenocarcinoma: assessing feasibility and limitations	16
Simple perinephric adipose tissue measurement for prediction of failed sentinel lymph node mapping in endometrial cancer	16
Survival outcomes in patients with recurrent mixed sex cord-stromal tumors of the ovary	16
HPV mRNA testing in cervical cancer screening: implications for low- and middle-income countries	16
Pelvic chondrosarcoma presenting as an adnexal mass treated with pubic bone resection	16
Fertility-sparing approach for uterine smooth muscle tumors of uncertain malignant potential	16
Oncological outcomes after laparotomic, laparoscopic, and robot-assisted laparoscopic staging for early high–intermediate or high-risk endometrial cancer	16
Treatment Tolerability Associated with Carboplatin Dose Based on Actual Versus Adjusted Body Weight in Patients with a BMI ≥ 25 kg/m2 with Advanced Ovarian Cancer	16
Overall survival after surgical staging by lymph node dissection versus sentinel lymph node biopsy in endometrial cancer: a national cancer database study	16
Racial and sociodemographic disparities in the use of targeted therapies in advanced ovarian cancer patients with Medicare	16
The benefit of sentinel lymph node evaluation in pre-operative grade 1 endometrial cancer	16
Long-term impact of surgical route and tumor size on risk of recurrence among early-stage cervical cancer patients in a managed care population	16
Ascites volume at the time of primary debulking and overall survival of patients with advanced epithelial ovarian cancer	15
Rare intra-tumoral colonization of Fusobacterium nucleatum in endometrial cancer	15
Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer	15
Risk factors for lymphedema and method of assessment in endometrial cancer: a prospective longitudinal multicenter study	15
Correspondence on ‘Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer’ by Luzarraga Aznar et al	15
Opioid and benzodiazepine use in gynecologic oncology patients	15
Expanding the workforce of clinical trial investigators committed to gynecologic cancer research: the GOG Foundation, Inc’s Scholar Career Development Award and New Investigator Program	15
Peritoneal cancer index: laparoscopic evaluation of peritoneal carcinomatosis from gynecological origin	15
Advanced metastatic G1 endometrioid endometrial carcinoma (no specific molecular profile group)	15
Low grade endometrioid endometrial cancer: complexities beyond p53abn	15
Some thoughts about surgery in ovarian cancer 2021	15
Response to: Correspondence on 'Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer' by Zhang and Sun	15
First workshop on cervix cancer surgery in Latin America: a hands-on experience from Lima, Perú	15
The tug of war: delivering safe gynecologic oncology treatment amid insecurity in Haiti	15
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions	14
Can the Tilburg Frailty Indicator predict post-operative quality of recovery in patients with gynecologic cancer? A prospective cohort study	14
Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation	14
Advanced ovarian yolk sac tumor: upfront surgery or neoadjuvant chemotherapy followed by interval debulking?	14
Proof-of-concept randomized phase II non-inferiority trial of simple versus type B2 hysterectomy in early-stage cervical cancer ≤2 cm (LESSER)	14
Rising endometrial cancer rates and potential for screening	14
Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer	14
Clinical and pathological overview of endometrial endometrioid carcinoma	14
Correspondence on “Complications of HIPEC for ovarian cancer surgery: evaluation over two time periods” by Navarro Santana et al	14
“Robot assisted utero-ovarian transposition and reanastomosis in vaginal cancer. A step-by-step description technique”.	13
GENE EXPRESSION BASED STUDY TO IDENTIFY POOR PROGNOSTIC INDICATORS IN CARCINOMA CERVIX	13
ANTERIOR EXENTERATION FOR MULTIFOCAL VAGINAL CARCINOMA	13
Long Term Outcomes In Patients Treated By Extensive Bowel Resection Due To Advanced Ovarian Cancer	13
MANAGEMENT OF A WOMAN WITH CERVICAL MELANOMA: A CASE REPORT AND LITERATURE REVIEW	13
Primary Ovarian Malignant Melanoma: A Case Report	13
12-Year Overall Survival And Prognostic Factors In Patients With FIGO Stage IA-IVA Vulvar Cancer Undergoing Surgery ± Adjuvant Radiation Therapy. Results From A Single Eastern European Center.	13
Squamous Cell Carcinoma Arising From A Mature Cystic Teratoma: A Rare Case	13
Addition of metronidazole to standard of care perioperative prophylaxis at time of hysterectomy for gynecologic malignancies	13
Evaluation Of Clitoral Artery Doppler Parameters After Brachytherapy And Its Effects On Sexual Functions	13
Gastric-type adenocarcinoma of the cervix in patients with Peutz-Jeghers syndrome: a systematic review of the literature with proposed screening guidelines	13
The Impact Of Hyperthermia On Cisplatin Cytotoxicity In Ovarian Cancer Cells	13
The Role Of Vaginal Microbiota And HPV DNA Methylation In Cervical Lesion Progression	12
Are We Facing A Paradigm Shift In The Treatment Of Advanced Ovarian Cancer? Neoadjuvant Therapy Vs Primary Surgery	12
Incidence And Impact Of Low Volume Lymph Node Metastasis In Apparent Early-Stage Ovarian Cancer – MICR-OVARY Study.	12
Is It Time To Revise Cervical Cancer Screening Guidelines?	12
Assessing The Implications Of Sentinel Lymph Node Removal In Cervical Cancer: An Immunogenetic Perspective – A SENTICOL/GINECO Ancillary Study	12
Treatment Strategies In Advanced Ovarian Cancer: Primary Cytoreductive Surgery And Adjuvant Chemotherapy Versus Neoadjuvant Chemotherapy And Interval Cytoreduction - A Single-Center Retrospective Obse	12
Exploring The Correlation Of Early Sexual Debut On Cervical HPV Infection In LMICs: Insights Through The Lens Of Sustainable Development Goals	12
Improving Postoperative Outcomes By Implementing A Gynaecological Oncology-Specific ERAS Pathway In A UK Gynaecological Cancer Centre.	12
Glyoxalase 1: A Promising Biomarker And Target For Cervical Cancer Treatment	12
Serous-Borderline Ovarian Tumors With Micropapillary Pattern Variants With Microinvasion Mimicking Advanced Stage Ovarian Carcinoma : A Rare Case Report	12
Parental Knowledge And Health Beliefs Of HPV Vaccination In Kuwait: A Cross-Sectional Descriptive Survey	12
Preoperative PET Scan Is Associated With Lower Rates Of Adjuvant Treatment In Surgically Treated Cervical Cancer Patients: A 4C Working Group Study	12
ARE ALL MISMATCH REPAIR DEFICIENT ENDOMETRIAL CANCERS CREATED EQUAL? A LARGE, RETROSPECTIVE, TERTIARY CENTER EXPERIENCE.	11
Abnormal Uterine Bleeding As A Predictor Of Endometrial Hyperplasia And Cancer Pathology In Postmenopausal Tamoxifen Treated Breast Cancer Patients	11
Survival After Incidental Cervical Cancer Diagnosis Following Simple Hysterectomy Compared To Planned Oncological Management In Tumors ≤2 Cm	11
Urinary Complications Of Bricker Procedures In Oncogynecology: A Monocentric Retrospective Analysis Of 77 Cases Over 20 Years	11
Topographic Distribution Of Histologically Confirmed Pelvic And Aortic Lymph Node Metastasis In Stage IIIC1r Locally Advanced Cervical Cancer: A Spain-GOG Retrospective Study.	11
Deep Dive Into No Specific Molecular Profile (NSMP) Endometrial Cancer: Unraveling Genomic Features According To Estrogen Receptor (ER) Expression	11
CLINICAL CHARACTERISTICS AND PROGNOSIS OF CLEAR CELL OVARIAN CARCINOMA IN A HOSPITAL IN PERU	10
Prospective Assessment Of The Association Between Perioperative Fluid Balance And Postoperative Complications After Surgery For Advanced Ovarian Cancer; Ancillary Data From A Randomised Controlled Tri	10
Bilateral oophorectomy and the probability of amnestic mild cognitive impairment among carriers of a pathogenic variant in BRCA1 or BRCA2	10
Mirvetuximab soravtansine shines post-PARP inhibitor progression: promising insights from the PICCOLO trial	10
Minimally Invasive Surgery In Early-Stage Ovarian Cancer: Recurrence Analysis	10

Brenner'S Tumors: An Update	10
Evaluation Of The MIDKINE Cytokine In Serum, Tumour Tissues And Lymph Nodes Of Patients With Endometrial Cancer	10
Evaluating Surgical Efficiency In Robotic-Assisted Hysterectomies For Endometrial Cancer And Benign Gynecologic Conditions	10
The Impact Of BRCA Status On The Efficacy Of Paclitaxel Monotherapy In Recurrent Ovarian Cancer	10
Comparison Of VNOTES And Laparoscopic Surgery In Patients With Ascites	10
The association of the chemotherapy response score and homologous recombination deficiency in patients undergoing interval tumor reductive surgery following neoadjuvant chemotherapy	10
Obesity In Endometrial Cancer - A Patient Treated With Curative Radiotherapy Using A Custom-Made 3D-Printed Applicator	10
Role of lymphadenectomy in advanced ovarian cancer—a subgroup analysis of the patients excluded from the LION trial (the Charité cohort)	10
Therapeutic Resistance In Synchronous Endometrioid Carcinomas: A Case Report With A Pathogenic Germline Mutation In PMS2	10
The Role Of Completion Surgery After Menopause In Women With Borderline Ovarian Tumors Treated With Fertility Sparing Surgery - A Multicenter Retrospective Cohort Study	10
Technical And Organizational Solutions For Research Endometrial Cancer Data Collection: The Ambispective, Multicentric ENDOCancer-DATA	10
Impact Of The COVID-19 Pandemic On Ovarian Cancer Diagnosis, Treatment, And Outcomes: A Systematic Review And Meta-Analysis	10
Comparative Efficacy Analysis Between Adjuvant Vaginal Cuff Brachytherapy And Pelvic External Beam Radiation Treatment For Women With FIGO Stage I Uterine Endometrioid Carcinoma With Pathologic Negati	10
Complete Resection After Interval Cytoreductive Surgery For Advanced Ovarian Cancer Subjected To Neoadjuvant Chemotherapy: A Systematic Review And Meta-Analysis Of Diagnostic Test Accuracy	10
Correspondence on ‘Cardiophrenic and costophrenic lymphadenectomy in advanced ovarian cancer by prediaphragmatic subxiphoid approach: PS technique’ by Stanciu	10
Exploring global barriers to optimal ovarian cancer care: thematic analysis	10
Journal Information	10
CDK7 Inhibition By THZ1 Triggers Pyroptosis And Enhances Immune Response In Ovarian Cancer	10
Impact Of Patient Characteristics On Primary Treatment Approach; A Population Based Study Regarding Incidence, Management And Outcome Of Endometrial Cancer Patients In The Netherlands Over 1995-2022	10
Solitary Splenic Metastasis In Endometrial Cancer - A Systematic Review And Case Presentation	10
Exceptional Survival And Carcinomatous Recurrence In Mixed Papillary Adenocarcinoma Of The Fallopian Tube: A Clinical Case Report	10
Tunisian Women’s Perception And Knowledge Of Cervical Cancer Screening: Are We Aware Yet?	9
Patients With Endometrial Cancer: Exploring Comorbidities And Quality Of Life – First Results Of An International Survey (NOGGO, ENGOT, GCIG - IMPROVE/EXPRESSION XI)	9
Introducing The Comprehensive Complication Index (CCI) To Gynecologic Oncology	9
Morbidities After Completion Surgery In Patients Treated For Locally Advanced Cervical Adenocarcinoma	9
Real-World Demographics And Survival Outcomes Of Patients In England With Advanced Or Recurrent Endometrial Cancer By Mismatch Repair Status	9
Accuracy And Performance Of Different Tracers In Sentinel Lymph Node Biopsy In Endometrial Cancer: A Single-Institution Retrospective Study	9
Obstetric And Oncology Outcomes Following Fertility-Sparing Surgery In Non-Epithelial Ovarian Cancer, Epithelial Ovarian Cancer And Borderline Ovarian Tumors: A Systematic Review And Meta-Analysis	9
Anterior Exenteration And Bricker Urinary Diversion For Cervical Cancer Recurrence	9
Radical Colpohysterectomy: A Step-By-Step Video Guide Of A Single-Patient Case	9
Obstetric Outcome Following Conservative Treatment Of Endometrial Carcinoma	9
Lymph Node And Distant Metastases In Staging And Re-Staging Of Uterine Cervical Cancer: Precise Diagnosis And Mapping Using FDG-PET/CT	9
Sentinel Lymph Node Mapping With Indocyanine Green In Endometrial Cancer	9
Beyond The Surface: The Impact Of Mucosal Bowel Invasion On Ovarian Cancer Staging	9
Comparison Of Microsatellite Instability Detection By Immunohistochemistry And Molecular Technique In Endometrial Cancer	9
ENDOESTRO-Score: Where Is The Dark Side? Evaluation Of Estrogen Receptor Expression Cut-Off In Endometrial Cancer Molecular Classification, A Retrospective Study	9
The Use Of Ambient Metabolomics To Enhance The Diagnosis And Treatment Of Cervical Precancer And Cancer	9
VIOLA Project: Preventing Vulvo-Vaginal Alterations Post-Treatment In Gynecological Cancer Patients	9
Predictive Value Of MRI Findings For Treatment Outcomes In Early Endometrial Cancer Patients Undergoing Fertility-Sparing Treatment	9
Does Size Matter? The Prognostic Role Of Lymph Node Metastasis Dimension In Endometrial Cancer Molecular Classification. A Multicentre, Retrospective Study	9
Analysis of the global burden of ovarian cancer in adolescents	8
Controversies in the Management of Mesonephric and Mesonephric-Like Adenocarcinomas of the Female Genital Tract	8
Beyond Trauma: A Survivor’s Story Of Cervical Carcinosarcoma	8
Survival Analysis And Comparison Between Routine And Selective Lymphadenectomy During Optimally Debulked Interval Cytoreductive Surgery In Women With Advanced Stage Carcinoma Ovary Post Neoadjuvant Ch	8
Malignant Struma Ovarii: A Series Case Report	8
Vulvar Cancer: Clinical Characteristics Of Patients In The Kasserine Region	8
Randomized Study Evaluating Optimal Dose, Efficacy And Safety Of E7386 + Lenvatinib Versus Treatment Of Physicians’ Choice In Advanced/Recurrent Endometrial Carcinoma Previously Treated With Anti-PD-(	8
Copy number variations in endometrial cancer: from biological significance to clinical utility	8
European multidisciplinary tumor boards support cross-border networking and increase treatment options for patients with rare gynecological tumors	8
Neuroendocrine cervical carcinomas: genomic insights, controversies in treatment strategies, and future directions: a NeCTuR study	8
Monophasic Synovial Sarcoma Of The Vulva: A Case Report And Literature Review	8
Ovarian Cancer And Severe COVID-19 Outcomes: A Matched Case-Control Study	8
The Immune-Silenced Dialogue In Endometrial Cancer Tumor Microenvironment Escape: Could The Volume Be Tuned Up By The Fetal-Maternal Immune Tolerance Cross-Talk?	8
The Association Between Postmenopausal Spontaneous Pyometra And Gynecological Cancer – The Experience Of A Tertiary Medical Center	8
Pelvic Exenteration: An Ultimate Option In Advanced Gynecologic Malignancies: A Single Center Experience	8
Terminal T-Cell Exhaustion Is A Prognostic Biomarker Of Clinical Outcome In Homologous Recombination Deficient Ovarian Cancer	8
Gracilis Flap For Vulvar Reconstruction In 10 Steps	8
Uterine transposition for fertility and ovarian function preservation after radiotherapy	8
Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy	8
Horseshoe kidney	8
Characterization Of The Immuno-Oncological Transcriptomic Landscape Of Uterine Smooth Muscle Tumors Of Uncertain Malignancy Potential (STUMP) According To Clinical Outcome	8
HPV Self-Collected Cervical Cancer Screening And Women Participation In Areas With Limited Access To Health Services In Colombia	8
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) WITH A CLOSED CO2 RECIRCULATION DEVICE IN PERITONEAL CARCINOMATOSIS FROM ADVANCED EPITHELIAL OVARIAN/TUBAL CANCER AFTER INTERVAL DEBULKING SURGERY (ID	8
Principles Of Laparoscopic Nerve Sparing Technique In Gynecological Surgery, Evaluation Of 290 Procedures	8
Unscheduled Bleeding In Postmenopausal Women On Hormone Replacement Therapy: A Single-Centre Analysis Of Endometrial Cancer Risk	8
Adenocarcinoma Of Anogenital Mammary-Like Glands – A Rare Primary Vulvar Tumor	8
Validation of the 2021 FIGO staging schema for advanced vulvar cancer	8
Upholding standard-of-care oncological treatment in the context of pregnancy	8
Uterine Carcinosarcoma (UCS): Literature Review And Survival Analysis From A Retrospective Cohort Study	8
Longitudinal Proteogenomic Analysis In High-Grade Serous Ovarian Cancer Patients Addressed To Neoadjuvant Chemotherapy Followed By Interval Debulking Surgery	7
Correspondence on “Oncologic outcomes based on lymphovascular space invasion in node- negative FIGO 2009 stage I endometrioid endometrial adenocarcinoma: a multicenter retrospective cohort study” by D	7
An Unusual Presentation Of A Submucous Leiomyoma In Non-Puerperal Uterine Inversion Etiology: A Rare Case Report	7
Diagnostic and treatment considerations for synchronous cancer of the ovary and endometrium	7
PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapy	7
Correspondence on ‘Sentinel lymph node assessment in patients with atypical endometrial hyperplasia: a systematic review and meta-analysis’ by Vieira-Serna et al	7
Huge cystic renal cell carcinoma misdiagnosed as ovarian cancer	7
Molecular and microenvironmental landscapes of human papillomavirus-independent invasive squamous cell carcinoma of the vulva	7
Prognostic Value Of Circulating Tumor DNA At Diagnosis And Its Early Decrease After One Cycle Of Neoadjuvant Chemotherapy For Patients With Advanced Epithelial Ovarian Cancer. An Ancillary Analysis Of	7
Management And Outcomes Of Patients With Bartholin Gland Carcinoma: Institut Curie’s 25-Year Experience	7
Men's role in women's health: Engaging male partners in cervical cancer prevention efforts in low-to-middle-income countries	7
Intraepithelial tumor-infiltrating lymphocytes shape loco-regional PET/CT spread of locally advanced cervical cancer	7
Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation	7
Serous endometrial intra-epithelial carcinoma: an observational study	7
Outcomes of open radical hysterectomy following implementation of an enhanced recovery after surgery program	7
From Resistance To Remission: Different Strategies In Treating High Risk GTN	7
Fasting And Breast Cancer: What Do Our Patients Believe?	7
SHR-2004, A Novel Humanised Monoclonal Antibody Targeting Factor XI (FXI), For Preventing Venous Thromboembolism (VTE) In Patients Undergoing Surgery For Ovarian Cancer: A Randomised, Active-Control P	7
Prevalence Among Human Papillomavirus Genotypes In Endocervical Samples From Asymptomatic Women In Cajamarca, Peru	7
Cost impact analysis of enhanced recovery after minimally invasive gynecologic oncology surgery	7
Patterns of spread and genetic alterations of primary endometrioid carcinomas of the ovary	7
Correspondence on 'ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*'	7
Secondary cytoreduction in platinum sensitive relapsed ovarian cancer: an individual patient level meta-analysis	7
Correction: Oncologic outcomes of uterine preservation for pre-menopausal patients with stage II epithelial ovarian carcinoma	7
Adjuvant external beam radiotherapy combined with brachytherapy for intermediate-risk cervical cancer	7
Breast Radiotherapy Experience: Patient'S Initial Fears And Expectations Versus Reality	7